CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net restructuring and other special charges	$ 12.6	$ 19.2
Operating Income (Loss)	687.9	1,057.9
Interest Expense	42.2	48.5
Equity method income, net	3.4	4.5
Investment income	1.1	2.4
Other, net	(10.1)	5.5
Earnings before income taxes	640.1	1,021.8
Provision for income taxes	148.0	251.7
Net earnings	492.1	770.1
Net Income (Loss) Attributable to Noncontrolling Interest	0.5	0.5
Net Income (Loss) Attributable to Parent	491.6	769.6
Revenues	3,899.6	4,161.5
Cost of Revenue	2,666.7	2,562.5
Gross Profit	1,232.9	1,599.0
Selling, general and administrative expenses	464.1	429.8
Amortization of intangibles and other assets	67.1	92.1
Asset Impairment Charges	1.2	0.0
Revenues	3,899.6	4,161.5
Cost of Revenue	2,666.7	2,562.5
Gross Profit	1,232.9	1,599.0
Selling, general and administrative expenses	464.1	429.8
Amortization of intangibles and other assets	67.1	92.1
Asset Impairment Charges	1.2	0.0
Net restructuring and other special charges	12.6	19.2
Operating Income (Loss)	687.9	1,057.9
Other income (expenses):
Interest expense	(42.2)	(48.5)
Equity method income, net	3.4	4.5
Investment income	1.1	2.4
Other, net	(10.1)	5.5
Earnings before income taxes	640.1	1,021.8
Provision for income taxes	148.0	251.7
Net earnings	492.1	770.1
Less: Net earnings attributable to the noncontrolling interest	(0.5)	(0.5)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 491.6	$ 769.6
Basic earnings per common share (in dollars per share)	$ 5.27	$ 7.88
Diluted earnings per common share (in dollars per share)	$ 5.23	$ 7.82